ZIVO Annual Current Liabilities
$2.76 M
+$733.90 K+36.19%
31 December 2023
Summary:
As of January 23, 2025, ZIVO annual total current liabilities is $2.76 million, with the most recent change of +$733.90 thousand (+36.19%) on December 31, 2023. During the last 3 years, it has fallen by -$8.63 million (-75.76%). ZIVO annual current liabilities is now -87.83% below its all-time high of $22.69 million, reached on December 31, 2018.ZIVO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO Quarterly Current Liabilities
$2.58 M
-$292.50 K-10.19%
30 September 2024
Summary:
As of January 23, 2025, ZIVO quarterly total current liabilities is $2.58 million, with the most recent change of -$292.50 thousand (-10.19%) on September 30, 2024. Over the past year, it has dropped by -$182.90 thousand (-6.62%). ZIVO quarterly current liabilities is now -89.60% below its all-time high of $24.80 million, reached on March 31, 2019.ZIVO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.2% | -6.6% |
| 3 y3 years | -75.8% | +27.2% |
| 5 y5 years | -87.8% | +27.2% |
ZIVO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.3% | +36.2% | -32.2% | +27.2% |
| 5 y | 5-year | -75.8% | +36.2% | -78.4% | +27.2% |
| alltime | all time | -87.8% | -89.6% |
ZIVO Bioscience Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.58 M(-10.2%) |
| June 2024 | - | $2.87 M(-6.9%) |
| Mar 2024 | - | $3.09 M(+11.7%) |
| Dec 2023 | $2.76 M(+36.2%) | $2.76 M(-13.0%) |
| Sept 2023 | - | $3.17 M(-16.6%) |
| June 2023 | - | $3.80 M(+36.3%) |
| Mar 2023 | - | $2.79 M(+37.6%) |
| Dec 2022 | $2.03 M(-31.2%) | $2.03 M(-12.4%) |
| Sept 2022 | - | $2.32 M(-14.2%) |
| June 2022 | - | $2.70 M(-8.9%) |
| Mar 2022 | - | $2.96 M(+0.4%) |
| Dec 2021 | $2.95 M(-74.1%) | $2.95 M(-16.9%) |
| Sept 2021 | - | $3.55 M(-2.6%) |
| June 2021 | - | $3.64 M(-69.5%) |
| Mar 2021 | - | $11.94 M(+4.8%) |
| Dec 2020 | $11.39 M(+30.8%) | $11.39 M(+2.7%) |
| Sept 2020 | - | $11.10 M(+10.0%) |
| June 2020 | - | $10.09 M(+8.2%) |
| Mar 2020 | - | $9.33 M(+7.1%) |
| Dec 2019 | $8.71 M(-61.6%) | $8.71 M(-20.6%) |
| Sept 2019 | - | $10.97 M(-2.6%) |
| June 2019 | - | $11.27 M(-54.6%) |
| Mar 2019 | - | $24.80 M(+9.3%) |
| Dec 2018 | $22.69 M(+397.6%) | $22.69 M(+3.9%) |
| Sept 2018 | - | $21.85 M(+11.6%) |
| June 2018 | - | $19.58 M(+235.2%) |
| Mar 2018 | - | $5.84 M(+28.1%) |
| Dec 2017 | $4.56 M(-59.2%) | $4.56 M(-75.8%) |
| Sept 2017 | - | $18.82 M(+619.0%) |
| June 2017 | - | $2.62 M(+3.8%) |
| Mar 2017 | - | $2.52 M(-77.5%) |
| Dec 2016 | $11.18 M(+125.0%) | $11.18 M(+66.9%) |
| Sept 2016 | - | $6.70 M(+5.8%) |
| June 2016 | - | $6.34 M(+13.6%) |
| Mar 2016 | - | $5.58 M(+12.2%) |
| Dec 2015 | $4.97 M(-20.3%) | $4.97 M(-40.3%) |
| Sept 2015 | - | $8.33 M(+15.9%) |
| June 2015 | - | $7.19 M(+4.3%) |
| Mar 2015 | - | $6.89 M(+10.6%) |
| Dec 2014 | $6.23 M(-42.7%) | $6.23 M(-31.9%) |
| Sept 2014 | - | $9.15 M(+54.8%) |
| June 2014 | - | $5.91 M(+4.5%) |
| Mar 2014 | - | $5.66 M(-48.0%) |
| Dec 2013 | $10.88 M(+223.6%) | $10.88 M(-9.4%) |
| Sept 2013 | - | $12.01 M(+37.9%) |
| June 2013 | - | $8.71 M(+88.5%) |
| Mar 2013 | - | $4.62 M(+37.5%) |
| Dec 2012 | $3.36 M | $3.36 M(+36.8%) |
| Sept 2012 | - | $2.46 M(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $2.53 M(+23.3%) |
| Mar 2012 | - | $2.05 M(+14.8%) |
| Dec 2011 | $1.79 M(+129.1%) | $1.79 M(+77.2%) |
| Sept 2011 | - | $1.01 M(+17.6%) |
| June 2011 | - | $858.60 K(-9.1%) |
| Mar 2011 | - | $944.10 K(+21.0%) |
| Dec 2010 | $780.50 K(-79.3%) | $780.50 K(-1.5%) |
| Sept 2010 | - | $792.30 K(-0.7%) |
| June 2010 | - | $797.50 K(-92.0%) |
| Mar 2010 | - | $10.00 M(+164.9%) |
| Dec 2009 | $3.77 M(+451.0%) | $3.77 M(+8.8%) |
| Sept 2009 | - | $3.47 M(+480.7%) |
| June 2009 | - | $597.50 K(-8.4%) |
| Mar 2009 | - | $652.00 K(-4.8%) |
| Dec 2008 | $685.10 K(+0.9%) | $685.10 K(+5.8%) |
| Sept 2008 | - | $647.40 K(+25.3%) |
| June 2008 | - | $516.80 K(+1.0%) |
| Mar 2008 | - | $511.90 K(-24.6%) |
| Dec 2007 | $678.80 K(-37.8%) | $678.80 K(+8.6%) |
| Sept 2007 | - | $624.80 K(-41.7%) |
| June 2007 | - | $1.07 M(-5.3%) |
| Mar 2007 | - | $1.13 M(+3.7%) |
| Dec 2006 | $1.09 M(-12.7%) | $1.09 M(-4.7%) |
| Sept 2006 | - | $1.15 M(-1.7%) |
| June 2006 | - | $1.17 M(-0.5%) |
| Mar 2006 | - | $1.17 M(-6.3%) |
| Dec 2005 | $1.25 M(+8.2%) | $1.25 M(-15.6%) |
| Sept 2005 | - | $1.48 M(-10.3%) |
| June 2005 | - | $1.65 M(+13.4%) |
| Mar 2005 | - | $1.46 M(+26.0%) |
| Dec 2004 | $1.16 M(+2423.4%) | $1.16 M(+90.4%) |
| Sept 2004 | - | $607.00 K(-11.4%) |
| June 2004 | - | $685.30 K(+80.2%) |
| Mar 2004 | - | $380.40 K(+730.6%) |
| Dec 2003 | $45.80 K(>+9900.0%) | $45.80 K(>+9900.0%) |
| Sept 2003 | - | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2002 | - | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) |
| June 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | $1600.00 | $1600.00(>+9900.0%) |
| Sept 2000 | - | $0.00(0.0%) |
| June 2000 | - | $0.00 |
FAQ
- What is ZIVO Bioscience annual total current liabilities?
- What is the all time high annual current liabilities for ZIVO Bioscience?
- What is ZIVO Bioscience annual current liabilities year-on-year change?
- What is ZIVO Bioscience quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly current liabilities year-on-year change?
What is ZIVO Bioscience annual total current liabilities?
The current annual current liabilities of ZIVO is $2.76 M
What is the all time high annual current liabilities for ZIVO Bioscience?
ZIVO Bioscience all-time high annual total current liabilities is $22.69 M
What is ZIVO Bioscience annual current liabilities year-on-year change?
Over the past year, ZIVO annual total current liabilities has changed by +$733.90 K (+36.19%)
What is ZIVO Bioscience quarterly total current liabilities?
The current quarterly current liabilities of ZIVO is $2.58 M
What is the all time high quarterly current liabilities for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly total current liabilities is $24.80 M
What is ZIVO Bioscience quarterly current liabilities year-on-year change?
Over the past year, ZIVO quarterly total current liabilities has changed by -$182.90 K (-6.62%)